Healthspan Horizons

What Healthspan Horizons does

Healthspan Horizons is a nonprofit research initiative and flagship program of the Buck Institute for Research on Aging's Price Lab, headquartered at 8001 Redwood Blvd., Novato, California. It operates a federated, AI-driven platform aimed at measuring, modeling, and extending healthspan — the years of life spent in good health — by integrating multi-omic (genomic, proteomic, metabolomic), clinical, behavioral, and environmental data on dense, longitudinal cohorts. The platform is positioned to serve four primary audiences: individual study participants contributing longitudinal data, academic and clinical research collaborators seeking cross-cohort analytics, industry partners in biotech/diagnostics/digital health/nutrition/wellness, and institutional buyers in payers, self-insured employers, and health systems exploring value-based models grounded in functional years gained rather than episodic utilization. Donors and philanthropists form a secondary supporter segment.

The core technology stack is built on a Trusted Research Environment (TRE) and a Federated AI Architecture aligned with FAIR, OMOP, and FHIR interoperability standards, allowing approved analyses across partner environments without requiring data centralization. Three named modules compose the platform: the Healthspan Compass, an AI-driven tool mapping individual data to aging trajectories across Metabolic, Immune, and Cognitive axes (preview/demos March 2026); the Healthspan Synthesizer, a federated analytics tool for researchers to test hypotheses across heterogeneous datasets (preview/demos March 2026); and the BioIntelligence Test, a multi-omic profiling product that generates personalized intervention recommendations with explanatory rationale. The proprietary SPANS Framework provides a biologically grounded translation layer from multimodal data to lived functional capacity, and a forthcoming Resilience Scores feature aims to quantify biological recovery capacity. AI capabilities — including multi-agent LLM systems, predictive trajectory modeling, anomaly detection for pre-clinical disease signals, and recommendation engines — are developed in-house by a dedicated team led by a Director of AI and Senior AI Scientist.

Healthspan Horizons is currently pre-revenue, with pricing not publicly disclosed and platform access rolling out in phases through 2026. The revenue model is anticipated to be subscription- or platform-access-based once Compass, Synthesizer, and BioIntelligence Test reach hands-on availability in late 2026, alongside sponsored research, partnership, and philanthropic pathways. The organization is funded primarily through an up to $52 million, four-year ARPA-H award for the Personalized Analytics for Transforming Health (PATH) initiative, executed jointly with Phenome Health and a national partner network, and is institutionally hosted by the Buck Institute for Research on Aging. International expansion is underway via the Buck–IHLAD Precision Health & Longevity Project with the UAE Institute for Health Longevity and Advanced Medicine.

Name

Healthspan Horizons

Legal name

Healthspan Horizons

Website

https://healthspanhorizons.org

Company type

Private

Founded year

2025

Operating status

Operating

Headcount range

1–10 employees

Short description

Healthspan Horizons is a nonprofit research initiative of the Buck Institute's Price Lab that operates a federated, AI-driven platform integrating multi-omics, clinical, and behavioral data to model personalized healthspan trajectories for researchers, health systems, payers, employers, and individual study participants.

Ownership category

akta.pro rank

Product category

Longevity Health Analytics Platform

NAICS

Software Publishers (5132), Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services (5182)

SIC

Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)

akta.pro primary industry

Bioinformatics & Multi-omics Analysis Software (HLAGAJAD)

akta.pro secondary industries

Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics) (HLAAANAF), AI/ML Platforms for Drug Discovery & Experiment Optimization (HLAGAJAO), Clinical & Translational Informatics (Clinical Data Integration/Real-World Data for R&D) (HLAGAJAF)

Keywords

• Multi-omics health analytics
• Federated AI platform
• Healthspan optimization
• Longevity research infrastructure
• Biomarker discovery

Headquarters

HQ city

Novato

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Software

Cost components

Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales

Revenue model

1. Platform Access & Study Participation (Pre-Revenue): Healthspan Horizons is in early launch phase. Platform products (Compass, Synthesizer, BioIntelligence Test) are launching in phases through 2026. Revenue model not yet publicly disclosed; company is operating as a research infrastructure initiative under the Buck Institute with grant funding.

Go-to-market motion2 records

Distribution channels5 records

Marketing channels8 records

Core offering

Healthspan Horizons builds an AI-driven federated data platform that integrates multi-omics (genomics, proteomics, metabolomics), clinical, behavioral, and environmental data to compute personalized healthspan trajectories. The platform comprises three primary modules — Healthspan Compass (personalized healthspan tracking), Healthspan Synthesizer (cross-cohort research analytics), and BioIntelligence Test (multi-omic intervention recommendations) — and underpins the Healthspan Horizons Study, a longitudinal research program.

Product overview

Healthspan Horizons is a research platform built by the Buck Institute for Research on Aging's Price Lab, operating as a federated, AI-driven healthspan optimization engine. The core Healthspan Horizons Platform integrates multi-modal real-world data from wearables, labs, and lifestyle engagement with deep discovery measurements to compute healthspan trajectories and detect early disease signals. It consists of three named modules: the Healthspan Compass (for mapping individual aging trajectories), the Healthspan Synthesizer (a federated AI analytics tool for cross-cohort research), and the BioIntelligence Test (a multi-omic test for personalized intervention recommendations). A forthcoming Resilience Scores feature aims to quantify biological recovery capacity. The initiative also includes the Healthspan Horizons Study — a large-scale longitudinal research program — and publishes scientific white papers and keynote perspectives on healthspan science.

Differentiator

Problem solved

Functional benefit

Brands

• Healthspan Compass: AI-driven component of the platform for personalized healthspan tracking and trajectory modeling
• Healthspan Synthesizer
• BioIntelligence Test
• Healthspan Horizons Study (HHS)
• Resilience Scores

Products and services

• Healthspan Horizons Platform AI-driven personalized healthspan optimization platform that connects multi-modal real-world data (wearables, labs, lifestyle) with deep discovery science and federated AI to compute healthspan trajectories, detect early disease signals, and generate personalized intervention recommendations.
• Healthspan Compass AI-driven component of the platform that maps individual health data to aging trajectories across Metabolic, Immune, and Cognitive axes and compares health states against genetic predispositions and peer groups to track progress and identify early changes before symptoms appear.
• Healthspan Synthesizer Federated AI platform tool that enables researchers and collaborators to explore complex multi-omic relationships, test hypotheses across heterogeneous datasets, and generate insights across cohorts without centralizing sensitive data.
• BioIntelligence Test Multi-omic test measuring genomics, proteomics, and metabolomics to determine which nutritional, lifestyle, or therapeutic interventions are most likely to extend an individual's healthspan, with explanatory rationale for each recommendation.
• Healthspan Horizons Study (HHS) Large-scale longitudinal research initiative in which individuals contribute health, lifestyle, and biological data over time in exchange for research-grade personalized insights into their healthspan trajectories.

Quantifiable outcome

• Extending healthy human lifespan by at least 10 years of vitality
• +1 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature7 records

Partnerships

Five partnerships are on record, tiered core, minor and major.

• Buck Institute for Research on AgingcoreOthersHealthspan Horizons is a flagship initiative of the Buck Institute's Price Lab. The Buck Institute is the organizational host and primary research institution, providing scientific credibility, infrastructure, and institutional backing. The Price Lab (led by Nathan Price) is the core scientific team.
• Phenome HealthcoreStrategic or Co-development PartnerPhenome Health is a key collaborator on the PATH (ARPA-H) initiative alongside the Buck Institute. Led by Lee Hood (advisor to Healthspan Horizons, National Medal of Science recipient), Phenome Health contributes to the national network of partners developing AI-driven health analytics.
• Fair HealthminorOthersHealthspan Horizons' federated architecture is aligned with FAIR principles, OMOP (Observational Medical Outcomes Partnership), and FHIR (Fast Healthcare Interoperability Resources) standards, enabling interoperability with healthcare data ecosystems.
• Institute for Systems Biology (ISB)minorStrategic or Co-development PartnerCo-founder Lee Hood (advisor) founded the Institute for Systems Biology. Healthspan Horizons draws heavily on systems biology methodologies pioneered at ISB, including multi-omic integration, network biology, and P4 (Predictive, Preventive, Personalized, Participatory) medicine frameworks.
• UAE Institute for Health Longevity and Advanced Medicine (IHLAD)majorStrategic or Co-development PartnerThe Buck–IHLAD Precision Health & Longevity Project (UAE) is listed as an active Healthspan Horizons project, indicating a significant international research collaboration focused on precision health and longevity.

Scale indicators5 records

Recent moves6 records

Expansion highlights6 records

Direct peers

• Phenome Health: Phenome Health, led by Lee Hood, is a co-collaborator on the ARPA-H PATH initiative and pursues population-scale multi-omic phenotyping to enable precision health — directly comparable mission and partnership.
• Human Longevity Inc. HLI offers whole-genome sequencing, advanced imaging, and AI-driven health insights toward preventive and longevity-focused care. Directly comparable multi-omics + AI healthspan playbook at much larger scale.
• Arivale: Co-founded by Nathan Price (also co-founder of Healthspan Horizons), Arivale was a direct-to-consumer scientific wellness platform combining multi-omics, lifestyle, and AI coaching. Most directly comparable as a predecessor / sister venture in the same scientific wellness category.
• InsideTracker: InsideTracker integrates blood biomarkers, DNA, and lifestyle data with AI to deliver personalized health and longevity recommendations. Closely comparable biomarker + AI-driven personalized healthspan offering.
• Viome Life Sciences: Viome combines gut metagenomics and transcriptomics with AI to deliver personalized nutrition and health recommendations. Comparable consumer-facing multi-omics + AI-driven personalized intervention model.

Emerging players

• Elysium Health: Elysium commercializes longevity science (e.g., Basis supplement) and partnered with TruDiagnostic on the Index Biological Age test. Comparable scientific credibility + biological age product positioning.
• TruDiagnostic: TruDiagnostic provides epigenetic and multi-omic biological age testing with AI-driven health insights. Closely comparable AI multi-omics biological age / healthspan product.
• Function Health: Function Health offers comprehensive at-home lab testing plus AI-driven insights to help individuals monitor and act on healthspan. Comparable preventive, multi-data-source healthspan play with consumer subscription model.

Broad incumbents

• Insitro: Insitro is an AI-driven drug discovery platform combining machine learning with high-throughput biology. Comparable AI + multi-omics platform playbook, though focused on therapeutic discovery rather than healthspan.
• Recursion Pharmaceuticals: Recursion combines high-dimensional biology with AI to accelerate drug discovery. Comparable AI + multi-omics infrastructure at scale, operating in adjacent biopharma R&D use case.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/healthspan-horizons

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Healthspan Horizons